scientific article; zbMATH DE number 2222299
From MaRDI portal
Publication:5701067
Recommendations
- Individual Prediction in Prostate Cancer Studies Using a Joint Longitudinal Survival–Cure Model
- Joint modelling of longitudinal and survival data in the presence of competing risks with applications to prostate cancer data
- Joint modeling of longitudinal and cure-survival data
- Joint modeling of longitudinal proportional measurements and survival time with a cure fraction
- A new approach for joint modelling of longitudinal measurements and survival times with a cure fraction
- A new joint model for longitudinal and survival data with a cure fraction
- Jointly modeling longitudinal proportional data and survival times with an application to the quality of life data in a breast cancer trial
- A stochastic model for survival of early prostate cancer with adjustments for leadtime, length bias, and over-detection
- Frequentist and Bayesian approaches for a joint model for prostate cancer risk and longitudinal prostate-specific antigen data
Cited in
(49)- Estimating a unitary effect summary based on combined survival and quantitative outcomes
- A stochastic model for prostate-specific antigen levels
- The new Neyman type A beta Weibull model with long-term survivors
- Vertical modeling: analysis of competing risks data with a cure fraction
- Joint modeling of longitudinal and cure-survival data
- A stochastic model for PSA levels: behavior of solutions and population statistics
- Joint model for left-censored longitudinal data, recurrent events and terminal event: predictive abilities of tumor burden for cancer evolution with application to the FFCD 2000--05 trial
- A characterization of missingness at random in a generalized shared-parameter joint modeling framework for longitudinal and time-to-event data, and sensitivity analysis
- Dynamic Predictions and Prospective Accuracy in Joint Models for Longitudinal and Time-to-Event Data
- Development and validation of a dynamic prognostic tool for prostate cancer recurrence using repeated measures of posttreatment PSA: a joint modeling approach
- A Two-Part Joint Model for the Analysis of Survival and Longitudinal Binary Data with Excess Zeros
- Semiparametric Modeling of Longitudinal Measurements and Time‐to‐Event Data–A Two‐Stage Regression Calibration Approach
- A Bayesian semiparametric survival model with longitudinal markers
- Individual Prediction in Prostate Cancer Studies Using a Joint Longitudinal Survival–Cure Model
- Fast fitting of joint models for longitudinal and event time data using a pseudo-adaptive Gaussian quadrature rule
- Latent Class Models for Joint Analysis of Longitudinal Biomarker and Event Process Data
- Bayesian influence measures for joint models for longitudinal and survival data
- Real-time individual predictions of prostate cancer recurrence using joint models
- A joint survival-longitudinal modelling approach for the dynamic prediction of rehospitalization in telemonitored chronic heart failure patients
- Joint model prediction and application to individual-level loss reserving
- Semiparametric random censorship models for survival data with long-term survivors
- Comparing crossing hazard rate functions by joint modelling of survival and longitudinal data
- Frequentist and Bayesian approaches for a joint model for prostate cancer risk and longitudinal prostate-specific antigen data
- Joint modelling of longitudinal biomarker and gap time between recurrent events: copula-based dependence
- A semiparametric Bayesian approach for joint modeling of longitudinal trait and event time
- Simulated maximum likelihood estimation in joint models for multiple longitudinal markers and recurrent events of multiple types, in the presence of a terminal event
- Joint models for multiple longitudinal processes and time-to-event outcome
- Joint modeling of longitudinal proportional measurements and survival time with a cure fraction
- Joint Modeling of Survival and Longitudinal Data: Likelihood Approach Revisited
- Bayesian approaches to joint longitudinal and survival models accommodating both zero and nonzero cure fractions
- The joint modeling of a longitudinal disease progression marker and the failure time process in the presence of cure
- Combining longitudinal studies of PSA
- Review and Comparison of Computational Approaches for Joint Longitudinal and Time‐to‐Event Models
- Mixture cure model methodology in survival analysis: some recent results for the one-sample case
- Investigation of one-stage meta-analysis methods for joint longitudinal and time-to-event data through simulation and real data application
- Joint Models for Event Prediction From Time Series and Survival Data
- A prediction model for colon cancer surveillance data
- Analysis of accelerated failure time data with dependent censoring using auxiliary variables via nonparametric multiple imputation
- An efficient joint model for high dimensional longitudinal and survival data via generic association features
- A Bayesian approach to joint analysis of multivariate longitudinal data and parametric accelerated failure time
- Joint longitudinal and survival-cure models in tumour xenograft experiments
- Joint modeling of two longitudinal outcomes and competing risk data
- Prediction of coronary artery disease risk based on multiple longitudinal biomarkers
- Estimating quality adjusted life years in the absence of standard utility values – a dynamic joint modeling approach
- Variational Bayesian analysis for joint models of longitudinal and failure time data with interval censoring
- Bayesian semi-parametric inference for clustered recurrent events with zero inflation and a terminal event
- Investigation of 2-stage meta-analysis methods for joint longitudinal and time-to-event data through simulation and real data application
- Joint modelling of longitudinal measurements and time-to-event outcomes with a cure fraction using functional principal component analysis
- Stochastic model for analysis of longitudinal data on aging and mortality
This page was built for publication:
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5701067)